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Abstract
Background: Lung maturation is modulated by several factors, including glucocorticoids. Expression of
hypothalamic-pituitary-adrenal (HPA) axis-related components, with proposed or described local regulatory systems
analogous to the HPA axis, was reported in peripheral tissues. Here, HPA axis-related genes were studied in the
mouse developing lung during a period overlapping the surge of surfactant production.
Methods: Expression of genes encoding for corticotropin-releasing hormone (CRH), CRH receptors (CRHR) 1 and
2beta, CRH-binding protein, proopiomelanocortin (POMC), melanocortin receptor 2 (MC2R), and glucocorticoid
receptor was quantified by real-time PCR and localized by in situ hydridization in fetal lungs at gestational days
(GD) 15.5, 16.5, and 17.5, and was also quantified in primary mesenchymal- and epithelial cell-enriched cultures. In
addition, the capability of CRH and adrenocorticotropic hormone (ACTH) to stimulate pulmonary expression of
enzymes involved in the adrenal pathway of glucocorticoid synthesis was addressed, as well as the glucocorticoid
production by fetal lung explants.
Results: We report that all the studied genes are expressed in fetal lungs according to different patterns. On GD
15.5, Mc2r showed peaks in expression in samples that have previously presented high mRNA levels for
glucocorticoid synthesizing enzymes, including 11beta-hydroxylase (Cyp11b1). Crhr1 mRNA co-localized with Pomc
mRNA in cells surrounding the proximal epithelium on GD 15.5 and 16.5. A transition in expression sites toward
distal epithelial cells was observed between GD 15.5 and 17.5 for all the studied genes. CRH or ACTH stimulation
of genes involved in the adrenal pathway of glucocorticoid synthesis was not observed in lung explants on GD
15.5, whereas CRH significantly increased expression of 21-hydroxylase (Cyp21a1) on GD 17.5. A
deoxycorticosterone production by fetal lung explants was observed.
Conclusions: Temporal and spatial modulations of expression of HPA axis-related genes in late gestation are
consistent with roles for these genes in lung development. Our data are likely to lead to valuable insights in
relation to lung diseases originating from lung immaturity.
Background
Corticotropin-releasing hormone (CRH) and adrenocor-
ticotropic hormone (ACTH) are classically involved in
the modulation of the hypothalamic-pituitary-adrenal
(HPA) axis, leading to secretion of glucocorticoids by
the adrenal glands [1,2]. CRH also has a role in regulat-
ing neuroendocrine functions, reproduction, and
immune functions [3]. The proopiomelanocortin (Pomc)
gene encodes for several peptides with various roles,
including ACTH, with highly tissue-specific regulation
and processing [4,5]. During gestation, glucocorticoids
of adrenal origin are involved in the maturation of many
fetal organ systems, including the lung [6,7]. Glucocorti-
coids are administered to pregnant women at risk of
premature delivery to accelerate fetal lung maturation
and to reduce the occurrence and severity of respiratory
distress syndrome (RDS) [8]. Their importance in fetal
lung development was highlighted by CRH-null and glu-
cocorticoid receptor (GR)-null mouse models, in which
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birth from respiratory failure [9,10].
Limited information is available on expression of
CRH, ACTH, and other HPA axis-related components
in the fetal lung. Crh mRNA was localized in fetal
mouse lungs around branching bronchioles [11], CRH
was detected in baboon fetal lungs [12], and POMC
mRNA was detected in ovine fetal lungs [13]. A direct
effect of CRH was demonstrated on differentiation and
proliferation of type II pneumocytes in baboon fetal
lung explants [14]. CRH receptor type 1 (CRHR1),
which is associated with pituitary ACTH secretion, was
detected at the mRNA level in baboon fetal lungs [14].
In addition, the melanocortin 2 receptor (MC2R), which
leads to glucocorticoid production in adrenal glands fol-
lowing binding to its only known ligand ACTH [5], was
detected in developing mouse lungs [15].
Expression of Crh and Pomc was shown in several
peripheral tissues [5,16], including thymus [17,18] and
s k i n[ 1 9 ] .I nt h el a t t e r ,C R H / A C T Hs i g n a l i n gw a s
reported, leading to local glucocorticoid production.
Brain, cardiovascular system, and thymus were also
identified as production sites of glucocorticoids invol-
ving an adrenal-like enzymatic pathway [20,21]. How-
ever, the implication of CRH and ACTH in these
glucocorticoid productions remains to be defined. Our
laboratory previously reported that genes involved in the
adrenal pathway of glucocorticoid synthesis, namely
steroidogenic acute regulatory protein (Star), cyto-
chrome P450 side chain cleavage (Cyp11a1), 3b-hydro-
xysteroid dehydrogenase (Hsd3b1), 21-hydroxylase
(Cyp21a1), and 11b-hydroxylase (Cyp11b1), are transi-
ently co-expressed at high levels in the fetal mouse lung
on gestational day (GD) 15 [22]. Whether this co-
expression is modulated by pituitary ACTH, by an auto-
crine/paracrine mechanism involving a local HPA
axis-like pathway, or by a CRH/ACTH-independent
mechanism, remains to be determined.
Based on data showing 1) the expression of HPA axis-
related genes in some peripheral tissues, 2) the existence
of a functional HPA axis-like pathway leading to gluco-
corticoid production in the skin, and 3) the transient
expression of genes involved in the adrenal pathway of
glucocorticoid synthesis in the murine fetal lung, we
hypothesized that HPA axis-related genes could be
developmentally regulated in the murine fetal lung and
that CRH and/or ACTH could be involved in the regu-
lation of fetal pulmonary expression of enzymes leading
to glucocorticoid production. In order to question their
involvement in lung development, HPA axis-related
genes were studied in the developing lung where their
e x p r e s s i o np r o f i l e sa sw e l la st h e i rs i t e so fe x p r e s s i o n
were investigated. For that purpose, Crh, Crhr1, Crhr2b,
Crhbp, Pomc, Mc2r,a n dNr3c1 (GR) were studied by
QPCR and in situ hybridization in male and female fetal
mouse lungs on GD 15.5, 16.5, and 17.5. This gestation
window overlaps the surge of surfactant production
occurring on GD 17.5 [23-25]. Immunoreactive ACTH
(iACTH) was also detected by immunohistochemistry.
The existence of a male disadvantage in the occurrence
of RDS [26], as well as the proposed transient delay for
one sex in the expression of genes involved in glucocor-
ticoid synthesis in the developing lung [22], warranted
the consideration of sex. Several adult tissues including
lung, spleen, thymus, brain, and adrenal gland were
included in QPCR experiments for comparison. Messen-
ger RNA levels were also measured in epithelial cell-
enriched and fibroblast-enriched primary cultures origi-
nating from mouse fetal lungs to further characterize
expression profiles of the target genes. In addition, fetal
lung explants were incubated in the presence of CRH or
ACTH to evaluate the capability of these hormones to
stimulate the expression of Pomc, Star, Hsd3b1,
Cyp21a1,a n dCyp11b1, and the glucocorticoid produc-
tion by fetal lung explants was addressed.
Methods
Animals, housing, and fetal tissue preparation
Protocol was approved by the Animal Care and Use
Committee and the Institutional Review Board of the
CHUQ Research Ctr (protocol no. 2008-071). BALB/c
mice (Mus musculus) aged 63-70 days and certified
pathogen-free were purchased (Charles River Labora-
tories, St-Constant, QC, Canada) and housed in a room
maintained at 22°C, 50% relative humidity and on a
12-hours cycle (07:15-19:15 hours) of fluorescent lighting
(300 Lux). Global 18% Protein Rodent Diet (Teklad,
Montréal, QC, Canada) and tap water were provided ad
libitum. New animals were acclimatized to these condi-
tions for 7-14 days prior to be mated. Fetuses were
obtained from overnight periods of mating. The day of
vaginal plug was considered as GD 0.5. Pregnant females
were sacrificed by exposure to a CO2 atmosphere. Fetal
sex was visually established and confirmed in some cases
by PCR amplification of Sry as previously described [27].
Lungs were rinsed thoroughly in phosphate buffered sal-
ine (PBS) and snap-frozen before storage at -80°C, or put
in 4% w/v paraformaldehyde for 48 hours and then paraf-
fin-embedded. Slices of 5 μmw e r ep r e p a r e df o rin situ
hybridization and immunohistochemistry experiments. A
minimum of three litters, including females and males,
were studied on GD 15.5, 16.5, and 17.5.
RNA probes
RNA probe templates were prepared from mouse lung
and brain cDNAs, as previously described [28]. Briefly, a
specific fragment of each studied gene was amplified
and inserted into pGEM-4Z (Promega Corp., Madison,
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tions are presented in Table 1. Antisense and sense
RNA probes were synthesized using DIG-UTP substrate
(Roche Diagnostics, Laval, QC, Canada) from PCR pro-
ducts amplified with specific primers for SP6 and T7
promoters: GGATTTAGGTGACACTATAGAATA and
TAATACGACTCACTATAGGGAGAC, respectively.
In situ hybridization and immunohistochemistry
In situ hybridization was performed as previously
described [28]. Hybridization with specific RNA probes
(5 ng/ul) was performed overnight at 42°C. Tissue sec-
tions were incubated in substrate solution [28] three
hours for Crh, Pomc,a n dNr3c1 or overnight for Crhr1,
Crhr2b, Crhbp,a n dMc2r. Immunohistochemistry was
performed as previously described [28]. The anti-
immunoreactive ACTH (iACTH) antibody (rabbit anti-
mouse; kindly provided by Dr Georges Pelletier, CHUQ
Research Ctr, [29]) and a rabbit IgG preparation (Vector
Laboratories Inc, Burlington, ON, Canada) were incu-
bated overnight at 4°C. Microscopy was performed with
a Zeiss Axioskop 2 Plus microscope (Carl Zeiss Canada,
Toronto, ON, Canada) equipped with Zeiss Plan-Neo-
fluar objectives. Images were acquired with a QImaging
Retiga 2000R camera (QImaging, Surrey, BC, Canada)
using the Image-Pro Plus 5.1 software (Media Cyber-
netics Inc, Bethesda, MD, USA).
Quantitative real-time PCR and normalization with
multiple housekeeping genes
RNA extraction and cDNA synthesis [30], and quantita-
tive real-time PCR [31], were performed as described
Table 1 Oligonucleotides and experimental parameters for QPCR, and oligonucleotides for in situ hydridization
probe synthesis, for experiments in mouse fetal lungs
Genes
a (NCBI) Oligonucleotides
b Amplicon length
(bp)
QPCR conditions
c
QPCR: forward/reverse RNA probes: forward/reverse Probe position Ann. T°
C
Acq. T°
C
#o f
cycles
Target genes
Pomc (NM_008895) CATTAGGCTTGGAGCAGGTC/TCTTGATGATGGCGTTCTTG 174 66 88 45
ACGTGGAAGATGCCGAGATTCTGCTACAGTC/CAGGAACAGCAGCAGTGC 141-433
Mc2r (NM_008560) CCTCTCTTTGCTGGGCTCTA/GCACCCTTCATGTTGGTTCT 321 63 83 40
CCTCTCTTTGCTGGGCTCTA/GCACCCTTCATGTTGGTTCT 589-909
Crh (NM_205769) CCTGGGGAATCTCAACAGAA/AACACGCGGAAAAAGTTAGC 120 62 89 45
TCCGCATGGGTGAAGAATAC/GGTGGAAGGTGAGATCCAGA 347-649
Crhbp (NM_198408) TCTTACCAGAAGGAGCATCAG/GTGTCCGAGGGTAAGATCAG 241 63 81 45
CGGGGATTTCCTGAAGGTAT/CTGCAGTTTTGGTGCTGGTA 469-768
Crhr1 (NM_007762) CCAGGATCAGCAGTGTGAGA/TGTTGTAGCGGACACCGTAG 161 64 86 43
CCAGGATCAGCAGTGTGAGA/AGTGGCCCAGGTAGTTGATG 265-372
Crhr2b
(NM_009953)
CAGGCCAGGCACCCCAGGAC/GGAACCACGCGATGTTTCTCAG 477 68 85 43
GGCTTTACCTTGGTGGGTAG/TGAAAAATTCCCAGTTGTGGTC 162-492
Nr3c1 (NM_008173) GGGGAATTCACAGACTTTCGGCTTCTGGA/
GGGAAGCTTCTGACCTCCAAGGACTCTCG
297 63 83 40
ACCTGGATGACCAAATGACC/AGGAGAGAAGCAGTAAGGTTTTCA 1821-2078
Mrap (NM_029844) TTCGTGGTGCTCCTCTTTCT/TCCTGGCTCCTCTGTTGTCT 162 63 85 43
Cyp21a1
(NM_009995)
CCTTGCCCCATCGTGCAACTA/TGGAGGCAGCAGAGTGAAGG 278 67 85 43
Vim (NM_011701) GATCAGCTCACCAACGACAA/AAGACGTGCCAGAGAAGCAT 170 62 84 40
Krt18 (NM_010664) GTGGAATCCAGACCGAGAAA/GTTCTTCCTTGAGTGCCTCG 406 58 84 40
Housekeeping genes
Gapdh
(NM_008084)
GTCGGTGTGAACGGATTTG/AAGATGGTGATGGGCTTCC 215 61 84 40
Hprt1 (NM_013556) AGTCCCAGCGTCGTGATTAG/AATCCAGCAGGTCAGCAAAG 228 64 82 40
Sdha (BC031849) ACACAGACCTGGTGGAGACC/CAAACGGCTTCTTCTGCTGT 179 59 84 45
aPomc, proopiomelanocortin; Mc2r, melanocortin receptor 2 (ACTH receptor); Crh, corticotropin releasing hormone; Crhbp, corticotropin releasing hormone
binding protein; Crhr1, corticotropin releasing hormone receptor 1; Crhr2b, corticotropin releasing hormone receptor 2b; Nr3c1, nuclear receptor subfamily 3,
group C, member 1 (glucocorticoid receptor); Mrap, melanocortin2 receptor accessory protein; Cyp21a1, 21-hydroxylase; Vim, vimentin; Krt18, keratin 18; Gapdh,
glyceraldehyde-3-phosphate dehydrogenase; Hprt1, hypoxanthine phosphoribosyltransferase 1; Sdha, succinate dehydrogenase complex, subunit A, flavoprotein.
bPrimer pairs used in QPCR experiments are presented. Primer pairs used to amplify and clone specific fragments to be used in RNA probe synthesis are
underlined. Primer pairs for cloning contain sequences for restriction endonucleases: forward primers, GGGGAATTC; reverse primers, GGGAAGCTT.
cAnn. T°C = annealing temperature; Acq. T°C = acquisition (fluorescence intensity reading) temperature.
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time PCR conditions are presented in Table 1, except
for Star, Hsd3b1,a n dCyp11b1 [22]. After enzyme acti-
vation (10 min, 95°C), PCR cycles were performed: 5
sec, denaturation 95°C; 5 sec, annealing (see Table 1 for
temperature); 20 sec, elongation 72°C; 5 sec, tempera-
ture of fluorescence intensi t yr e a d i n g( s e eT a b l e1 ) .
Expression stability of three housekeeping genes
(Gapdh, Hprt1, Sdha) was assessed based on the
approach proposed by Vandesompele et al [32]. Then,
normalization factors were calculated from expression
levels of the three housekeeping genes.
Preparation of fibroblast- and epithelial cell-enriched
cultures from fetal mouse lungs
Fetal lungs were removed, rinsed in PBS, cut into pieces
of approximately 2 mm
3, and extensively rinsed again in
PBS. Digestion was made in Hank’s buffered saline solu-
tion (HBSS) (Multicell, Wisent Inc., St-Bruno, QC,
Canada) containing 0.25% w/v trypsin (Multicell), 0.17%
w/v collagenase (Sigma, St. Louis, MO, USA), DNAse I
(25 μg/ml) (Sigma), penicillin (50 iu)/streptomycin (50
μg/ml) (Multicell), and gentamycin (5 μg / m l )( S i g m a )a t
37°C for 30 minutes under agitation. Digestion was
stopped by addition of Dulbecco’s modified eagle’s med-
ium (DMEM) (Multicell) containing 20% v/v fetal
bovine serum (FBS) (Sigma). Residual tissue debris were
discarded by 1 × g sedimentation and then, supernatants
were centrifuged 7 min at 100 × g. Cell pellets were
resuspended in DMEM containing 20% v/v FBS and
penicillin (50 iu)/streptomycin (50 μg/ml). Cells were
incubated for one hour at 37°C with 5% CO2 to allow
fibroblast adhesion. Then, culture media were removed
and the fibroblast adhesion step was repeated twice. The
epithelial cell-enriched fractions (non-adherent cells)
were collected and filtered through a sterile 45 μmc e l l
strainer (VWR International, Montréal, QC, Canada),
centrifuged 7 min at 100 × g and then plated in 12-well
plates. Cell cultures were kept 12 hours at 37°C under
5% CO2 atmosphere. Cell phenotypes were visually con-
firmed before harvesting. Epithelial cell-enriched cul-
tures were then homogenized in TRI Reagent
(Molecular Research Center, Cincinnati, OH, USA) for
RNA extraction. Fibroblast-enriched cultures were fil-
tered through a sterile 45 μm cell strainer before RNA
extraction. Three separate cell enrichment experiments
with 2-3 litters each were done at GD15.5 (total n = 44
fetal lungs) and four were done at GD17.5 (total n = 42
fetal lungs). Given the low number of epithelial cells
recovered at GD15.5, RNA extracts were pooled before
cDNA preparation. At GD17.5, enough epithelial cells
for cDNA synthesis were recovered in 2 out of 4
experiments.
Incubation of lung explants with CRH or ACTH
GD 15.5 and 17.5 fetal lungs were removed, rinsed in
PBS, and incubated 8 h in DMEM containing penicillin
(50 iu)/streptomycin (50 μg/ml) and 10
-7 MC R H
(C3042, Sigma) or 10
-7 M ACTH (Cortrosyn, Amphastar
Pharmaceuticals Inc., Rancho Cucamonga, CA, USA) at
37°C under gentle agitation. Three and four litters were
analyzed at GD 15.5 and 17.5, respectively, with 1 to 3
fetal lungs per condition (control, CRH, and ACTH) for
each litter. Explants were then homogenized in TRI
reagent and stored at -80°C until RNA extraction.
Steroidogenic activity measures
Deoxycorticosterone (DOC) production was measured in
control and CRH-treated-GD17.5 lung explants. Five
litters were used, with 2-3 fetal lungs per litter per condi-
tion. The explants were incubated in 1 mL of DMEM
containing pen/strep a first 3 h with 2 × 10
-7 MC R Ho r
without, then 5 h with 2 × 10
-7 M CRH or without in the
presence of [1,2,6,7-
3H(N)]progesterone at 58 nM (6 μCi/
well) (Perkin Elmer, Boston, MA) and unlabeled DOC
(Steraloids, Wilton, NH) at 10
-5 M. Unlabeled DOC was
added to reduce metabolization of tritiated DOC. Ster-
oids were extracted from culture media with chlorobu-
tane, and resolved by thin layer chromatography (toluene
78: acetone 20: methanol 2). Tritiated standards of
progesterone, DOC, and corticosterone were included.
Revelation of the tritiated products and quantification
were performed using a Storm apparatus (Molecular
Dynamics, Inc., Sunnyvale, CA). Data are expressed as
deoxycorticosterone radioactivity count/total radioactiv-
ity count/mg tissue.
Statistical analysis
Statistical analyses were performed using GraphPad
Prism 5.01 software (GraphPad Software, La Jolla, CA,
USA). Two-way ANOVA with randomized-block design
was used for QPCR experiments on total fetal lung
extracts, where male and female values were matched.
One-way ANOVA with randomized-block design fol-
l o w e db yaT u k e y ’s test was used for experiments with
lung explants incubated with CRH or ACTH, where
samples from the same litter were matched. Paired t-test
was used to analyze data of deoxycorticosterone quanti-
fication, where mean control samples and mean treated
samples from each litter were paired. When normality
of data could not be assumed following a normality test
in GraphPad Prism, logN transformation was performed.
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ered as significant.
Results
Expression levels of HPA axis-related genes in male and
female fetal mouse lungs
The gene expression profiles of Crh, Crhbp, Crhr1,
Crhr2b, Pomc, Mc2r,a n dNr3c1 were determined in
male and female fetal lung pools from several mouse lit-
ters collected on GD 15.5, 16.5, and 17.5 (Figure 1). Sev-
eral mature tissues were included for reference. To give
estimates of raw mRNA levels in fetal lungs, mean
crossing point values are presented in Table 2.
Crh mRNA levels were higher in fetal lung samples
than in other tissues, including total brain (Figure 1A).
In addition, a trend in increase in Crh mRNA levels
was observed according to gestation time (p = 0.053).
For Crhbp mRNA levels (Figure 1B), a significant inter-
action between time and sex (p = 0.019), as well as a
significant impact of sex (p = 0.017), were observed.
Moreover, expression levels tend to decrease according
to gestational age. A high Crhbp mRNA level was
detected in brain, which is recognized as the major
expression site of this gene [33]. Very low levels of
Crhr1 mRNA were observed in several fetal lung sam-
p l e s( F i g u r e1 C ;T a b l e2 ) ,w h i l en oe x p r e s s i o nw a s
detected in the others. For comparison, brain and
spleen expressed Crhr1 mRNA at relatively high levels,
and no expression was detected in adult lung and adre-
nal gland. Crhr2b expression in fetal lung samples
showed more interindividual variability than the other
considered genes (Figure 1D), but no significant effect
of time or sex was observed. A higher mRNA level was
detected in adult lung than in the other control tissues.
Pomc mRNA levels were similar between fetal lungs
and adult tissues, except for adrenal gland in which
expression level was very low (Figure 1E). Mc2r mRNA
was detected in fetal lungs and was found to be
expressed at much higher levels in two GD 15.5 sam-
ples (one female pool and one male pool) (Figure 1F).
These two samples were previously shown to express
high levels of genes involved in the adrenal glucocorti-
coid synthesis pathway (samples 70 F and 71 M in
[22]). As expected, the expression level of Mc2r in adre-
nal gland was very high. No significant effect of time or
sex was observed for Pomc and Mc2r.G e n ee x p r e s s i o n
of melanocortin receptor associated protein (MRAP),
which is important in MC2R signaling [34], was also
detected in fetal lung samples (Table 2 and data not
shown). High Nr3c1 mRNA levels were detected in fetal
lungs (Table 2) and a significant increase in expression
was observed over time (about 2-fold between GD 15.5
and 17.5, p = 0.0003) (Figure 1G). Among the analyzed
mature tissues, the highest Nr3c1 expression level was
observed in the lung.
Expression sites of HPA axis-related genes in male and
female fetal mouse lungs
In situ hybridization was performed on male and female
fetal mouse lungs from GD 15.5, 16.5, and 17.5 to loca-
lize expression sites of Crh, Crhbp, Crhr1, Crhr2b,
Pomc, Mc2r,a n dNr3c1 (Figures 2, 3, and data not
shown). In addition, iACTH was detected by immuno-
histochemistry (Figure 2).
Crhr1 and Pomc mRNAs were localized on GD 15.5
and 16.5 in cells surrounding epithelial cells of conduct-
ing zones (Figure 2A-C, F-H), whereas iACTH protein
was detected in epithelial cells (Figure 2K-M). On GD
17.5, Pomc and iACTH signals were strong in epithelial
cells of distal zones (Figure 2I and 2N). Adult pituitary
gland was used as positive control and, as expected,
Crhr1, Pomc, and iACTH were localized in intermediate
and anterior lobes (Figure 2E J, and 2O) [35].
For Crh, Crhbp, Crhr2b, Mc2r,a n dNr3c1 mRNAs,
positive signals were widely distributed on GD 15.5 (Fig-
u r e3 A ,C ,E ,G ,a n d3 I )a n d1 6 . 5( d a t an o ts h o w n ) .
However, no signal was observed in epithelial cells of
conducting zones, except for a few cells. For these five
genes, as for Crhr1 and Pomc, an important change in
expression sites is observed when tissues originating
from GD 15.5-16.5 and GD 17.5 are compared, the dis-
tal epithelium being the major site of expression on GD
17.5 (Figure 3B, D, F, H, and 3J). Nr3c1 mRNA was also
detected in mesenchymal cells, although at lower levels
than in epithelial cells. For every gene studied, no sex
difference was observed in mRNA expression sites.
Expression levels of HPA axis-related genes in primary
cell cultures derived from fetal mouse lungs
Next, we determined whether the transition in gene
expression sites from GD 15.5 to 17.5 can be observed
in cell cultures. Levels of Crh, Crhbp, Crhr1, Crhr2b,
Pomc, Mc2r,a n dNr3c1 mRNAs were compared
between fibroblast-enriched cell cultures, epithelial cell-
enriched cell cultures, and total lungs. Fetal sex was not
considered in these experiments because only Crhbp
showed a sex difference in expression by QPCR in
whole lungs, whereas no sex difference was observed for
any of these genes by in situ hybridization. Messenger
RNA levels of Krt18 and Vim, which are epithelial and
mesenchymal markers, respectively, confirmed cell
enrichments (Figure 4C). For each analyzed gene, ratios
corresponding to mRNA levels in epithelial cell-enriched
cultures over those in fibroblast-enriched cultures are
presented in Figure 4D. Interestingly, Crh mRNA was
not or barely detected in cell cultures. On GD 15.5 and
17.5, Crhr1 mRNA was detected in mesenchymal cells,
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Page 5 of 14Figure 1 Relative mRNA expression levels of HPA axis-related genes in mouse fetal lungs. Crh (A), Crhbp (B), Crhr1 (C), Crhr2b (D), Pomc
(E), Mc2r (F), and Nr3c1 (G) were quantified by QPCR in male and female total fetal lung extracts from several litters on GD 15.5, 16.5, and 17.5.
For each litter, the black bar represents the male pool and the white bar represents the female pool. Dashed bars represent adult tissues.
Number of animals in each litter (litter #: number of males (M), number of females (F)): #1: 2 M, 2 F; #2: 4 M, 5 F; #3: 4 M, 3 F; #4: 2 M, 3 F; #5:
3M, 6 F; #6: 4 M, 3 F; #7: 1 M, 2 F; #8: 4 M, 4 F; #9: 3 M, 4 F; #10: 3 M, 1 F. Each value (± SD) was normalized using a factor generated from
expression values of three housekeeping genes, namely Hprt1, Sdha, and Gapdh. ANOVA was performed to evaluate the effect of time and sex.
A trend in increase in Crh mRNA levels was observed according to gestation time (p = 0.053) (A), a significant interaction between time and sex
(p = 0.019), as well as a significant impact of sex (p = 0.017), were observed for Crhbp mRNA levels (B), and a significant increase in Nr3c1 mRNA
levels was observed over time (p = 0.0003) (G).
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epithelial cells. On GD 15.5, Crhr2b expression level
was higher in mesenchymal cells than in epithelial cells,
while on GD 17.5 the opposite situation was observed.
Crhr2b mRNA was not detected in all samples. Crhr1
and Crhr2b mRNA levels were lower in cell cultures
than in whole fetal lungs, similarly to Crh (data not
shown). The expression of Crhbp was higher in epithe-
lial cells than in fibroblasts on GD 15.5 and 17.5, while
Pomc, Mc2r,a n dNr3c1 are preferentially expressed in
fibroblasts on GD 15.5 and in epithelial cells on GD
17.5 (Figure 4D). Expression levels of these last four
genes were similar between cell cultures and total lung
pools (data not shown).
Expression of Cyp21a1 and Cyp11b1 in fetal mouse lungs
and fetal lung primary cell cultures
Cyp21a1 and Cyp11b1 encode the last two steroidogenic
enzymes involved in de novo corticosterone synthesis
[36,37]. Cyp11b1 expression was previously observed on
GD 15.5, but not on GD 16.5, 17.5, and 18.5 in the fetal
lung [22]. There was no available data on expression of
Table 2 Mean crossing point (cp) values of the amplified genes in mouse fetal lungs
Target genes Housekeeping genes
Crh Crhbp Crhr1 Crhr2b Pomc Mc2r Nr3c1 Mrap Hprt1 Sdha Gapdh
Mean cp ±
SD
a
36.03 ±
1.49
35.58 ±
1.92
35.49 ±
1.35
32.68 ±
1.50
35.13 ±
1.24
33.46 ±
2.06
24.05 ±
1.98
32.87 ±
0.64
23.15 ±
1.45
24.10 ±
1.43
17.86 ±
0.70
aMean crossing points (cp) ± SD were calculated using GD 15.5, 16.5, and 17.5 mouse fetal lungs. The values are estimations of the relative abundance of the
indicated mRNAs (n = 16-20 pools). Samples in which no expression was detected were not included. The lower value, the higher mRNA abundance.
Figure 2 Distribution of Crhr1 mRNA, Pomc mRNA, and immunoreactive (i) ACTH protein in mouse fetal lungs. Tissue sections are from
GD 15.5 (A, B, F, G, K and L), 16.5 (C, H and M) or 17.5 (D, I and N). Adult mouse pituitary sections are used as positive control (E, J and O). In
situ hybridization was performed using anti-sense probes (A to J, positive signal is blue), while immunohistochemistry was performed using an
anti-iACTH polyclonal antibody (K to O, positive signal is red). No staining was observed using corresponding sense probes (negative controls,
data not shown). On GD 15.5, expression of Crhr1 (A and B) and Pomc (F and G) was observed in cells surrounding airways and a change in
expression sites toward distal epithelial cells was observed according to developmental time. On GD 15.5 (K and L), 16.5 (M), and 17.5 (N), iACTH
was detected in epithelial cells. Scale bars, 100 μm (A, E, F, J, K and O) or 50 μm (B to D, G to I and L to N). AL, anterior lobe; CZ, conducting
zone; E, epithelial cells; EC, endothelial cells; IL, intermediary lobe; M, mesenchyme; PL, posterior lobe; RZ, respiratory zone; SM, smooth muscle.
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Page 7 of 14Figure 3 Distribution of Crh, Crhbp, Crhr2b, Mc2r, and Nr3c1 mRNAs in mouse fetal lungs. Mouse tissue sections are from GD 15.5 (A, C, E,
G and I) or 17.5 (B, D, F, H and J). In situ hybridization was performed using anti-sense probes (A to J, positive signal is blue). No staining was
observed using corresponding sense probes (negative controls, data not shown). Results obtained on GD 16.5 (data not shown) are similar to
those obtained on GD 15.5 for all the genes. A change in expression sites between GD 15.5-16.5 versus 17.5 was observed. Expression of mRNAs
encoding for all the analyzed genes was observed in epithelial cells of distal zones on GD 17.5. Scale bars, 50 μm (A to J). CZ, conducting zone;
E, epithelial cells; EC, endothelial cell; M, mesenchyme; RZ, respiratory zone; SM, smooth muscle.
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Page 8 of 14Cyp21a1 after GD 15.5. We detected Cyp21a1 mRNA in
fetal lung pools and in lung explants obtained on GD
17.5 (data not shown). Interestingly, Cyp21a1 mRNA
was detected at much higher levels in primary cell cul-
tures than in non-incubated whole lung samples and
lung explants. Indeed, Cyp21a1 mRNA levels were ~15
and ~40 fold higher in fibroblast- and in epithelial cell-
enriched cultures, respectively, than in lung explants
(data not shown), and were higher in epithelial fractions
than in fibroblast fractions on both GD 15.5 and 17.5
(Figure 4D). In agreement with previous data, Cyp11b1
mRNA was not detected in lung explants obtained on
Figure 4 Relative mRNA expression levels of HPA axis-related genes in differential cell cultures derived from fetal mouse lungs. Crh,
Crhbp, Crhr1, Crhr2b, Pomc, Mc2r, Cyp21a1, Cyp11b1, and Nr3c1 were quantified by QPCR in fibroblast-enriched and in epithelial cell-enriched
primary cultures originating from GD 15.5 and 17.5 fetal mouse lungs. Representative cultures of mesenchymal cells (A) and epithelial cells (B)
are presented. Expression ratios of Krt18 (cytokeratin 18; epithelial cell marker) on Vim (vimentin; mesenchymal cell marker) were assessed to
confirm cell enrichment (C). For each studied gene, ratios of expression levels in epithelial cells over expression levels in mesenchymal cells are
presented (D). Genes for which all or some of the samples were negative are presented in the inset. Values that are over the dashed line
represent higher expression level in epithelial cell-enriched cultures. ND, not detected; E, epithelial cell-enriched cultures; F, fibroblast-enriched
cultures.
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Page 9 of 14GD 17.5 in the present study. However, Cyp11b1 mRNA
was surprisingly detected at relatively high levels in cell
cultures, as Cyp21a1.
The potential effect of reciprocal exposure of epithelial-
and mesenchymal-enriched cell cultures to their respec-
tive secreted factors on gene expression of Crh, Crhr1,
Crhr2b, Cyp21a1,a n dCyp11b1 was addressed. Target
gene mRNA levels were quantified in epithelial- and
mesenchymal-enriched cells after co-culture using por-
ous filters (0.1 μm) during 96 h (n = 16 fetal lungs from 3
litters). Crhr2b mRNA level was 4-fold higher in co-
cultured fibroblasts than in fibroblasts cultured alone.
For the other analyzed genes, results obtained from co-
cultured cells were similar to those from separated cells
(data not shown).
Incubation of fetal mouse lung explants in the presence
of CRH or ACTH, and determination of glucocorticoid
formation
GD 15.5 and 17.5 lung explants were incubated in the
presence of CRH or ACTH to evaluate the potential
modulatory roles of these hormones on mRNA levels of
Pomc, Star, Hsd3b1, Cyp21a1,a n dCyp11b1.T h ef e t a l
sex was not considered for the reasons exposed above.
No effect of CRH or ACTH was observed on GD 15.5
on the expression level of any of the studied genes (data
not shown). On GD 17.5, a significant stimulatory effect
of CRH (n = 4, ANOVA, p = 0.0307; Tukey’s test Ctl vs
CRH, p < 0.05) was observed on Cyp21a1 mRNA levels
(Figure 5). No significant effect was observed on Pomc,
Star,a n dHsd3b1 expression. To determine whether the
CRH-induced increase in Cyp21a1 expression leads to
increased enzymatic activity, we measured the level of
newly-formed tritiated deoxycorticosterone in control
and CRH-treated fetal lung explants isolated on GD17.5
using tritiated progesterone as substrate. Unlabeled
deoxycorticosterone was added to reduce metabolization
of newly-formed tritiated deoxycorticosterone. Accumu-
lation of tritiated deoxycorticosterone was detected in
all samples, and a non-statistically significant 25%
increase of deoxycorticosterone production was
observed in CRH-treated samples compared to controls
(paired t-test, p = 0.36) (data not shown). No corticos-
terone accumulation was detected.
Discussion
We report expression of HPA axis-related genes in the
fetal lung during late gestation, a period that includes
the surge of surfactant synthesis occurring on GD 17 in
the mouse. More precisely, we present expression pro-
files of Crh, Crhr1, Crhr2b, Crhbp, Pomc, Mc2r,a n d
Nr3c1 and we also report marked co-expression of Mc2r
with genes encoding for glucocorticoid synthesizing
enzymes from cholesterol on GD 15.5. We show that
Crhr1 and Pomc mRNAs are localized in cells surround-
ing proximal epithelia where iACTH is detected on GD
15.5 and 16.5, and that a major switch in expression
sites toward epithelial cells of distal zones occurred
between GD 15.5 and 17.5 for all the studied genes. In
addition, a significant CRH-modulated increase in
Cyp21a1 expression was observed in fetal lung explants
isolated on GD 17.5 as well as a deoxycorticosterone
production by fetal lung explants. Even though our data
do not suggest a functional HPA axis regulating the pre-
viously reported pathway of glucocorticoid synthesis on
GD 15, they support roles for HPA axis-related compo-
nents, as well as autocrine/paracrine actions of CRH
and ACTH, in developing lungs.
In several species, a local metabolism of glucocorti-
coids through the action of 11b-hydroxysteroid dehydro-
genases (11bHSDs) was shown in the developing lung
where it leads to a net increased formation of active glu-
cocorticoids by the predominant 11bHSD type 1 activity
[38-42]. It was also reported that the fetal mouse lung
expresses all the genes involved in glucocorticoid synth-
esis from cholesterol [22]. High expression of the latter
genes was observed in several litters on GD 15 but only
in male or female lung pools according to the analyzed
litter, and this occurred before an important rise in
Hsd11b1 expression [22]. Interestingly, in the present
study, Mc2r was highly expressed in the same pools
Figure 5 Effects of exogenous CRH or ACTH on expression
levels of Pomc, Star, Hsd3b1, and Cyp21a1 in mouse fetal lung
explants. Fetal lungs were harvested on GD 17.5 and incubated 8h
in the presence of 10
-7 M CRH or 10
-7 M ACTH. Messenger RNA
levels of Pomc, Star, Hsd3b1, and Cyp21a1 were measured by QPCR
in control and treated lungs. Data are presented as ratios of treated
samples over control samples ± SEM. Experiments were performed
with 1 to 3 fetal lungs per condition per litter (n = 4 litters), and
statistical analysis was performed using one-way ANOVA with
randomized-block design (samples within each litter were matched).
*, P < 0.05.
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Page 10 of 14where the genes involved in glucocorticoid synthesis
from cholesterol showed high expression levels, thus
suggesting a role for Mc2r in the control of the “adre-
nal” pathway of glucocorticoid synthesis in the fetal
lung. Accordingly, expression of Mrap was detected in
fetal lung samples, the expression of this gene being
necessary for MC2R signaling [34]. We localized a weak
Mc2r mRNA signal in distal epithelial cells and in the
mesenchyme on GD 15.5, while staining in epithelial
cells was more intense on GD 17.5. MC2R was pre-
viously detected by immunohistochemistry in fetal
mouse lungs from GD 11.5 to 14.5 in the bronchial
epithelium and in the mesenchyme [15]. Taken together,
these observations suggest that the site of Mc2r expres-
sion varies according to gestational time. Expression of
Mc2r has been shown to be regulated temporally in the
fetal testis [43], as in the fetal lung.
In the present study, incubation of lung explants iso-
l a t e do nG D1 5 . 5w i t hC R Ho rA C T Hd i dn o tu p -
regulate the genes involved in the “adrenal” pathway of
glucocorticoid synthesis. A postulated narrow window of
CRH and/or ACTH receptivity may explain the absence
of stimulation. Indeed, the fast progression of tissue
development observed in the mouse where gestation is
completed after only 19 days adds to the difficulty to
characterize transitory events occurring within a very
narrow developmental time window. Alternatively, it is
not excluded that the previously reported transient co-
expression of the five genes of the “adrenal” pathway
may not be dependant on the presence of CRH and/or
ACTH. Nevertheless, a significant increase in Cyp21a1
mRNA expression was observed in lung explants iso-
lated on GD 17.5 following incubation with CRH, along
with a 25% increased deoxycorticosterone production
(p = 0.36). The high expression levels previously
observed on GD 15 for the genes of the cascade were
not reached in both control and stimulated lung
explants in the present study, suggesting that the absent
or modest activation of expression reported here for
these genes is not a consequence of a saturated system
caused by endogenous CRH and ACTH production.
After GD 15.5, 21-hydroxylase may not be involved in
corticosterone synthesis since Cyp11b1 mRNA is neither
expressed in intact tissue [22] nor stimulated following
CRH or ACTH incubations in lung explants (Figure 5).
A common observation to both adult mouse lung [21]
and fetal lung after GD 15.5 is that expression of
Cyp11a1 and Cyp21a1, but not that of Cyp11b1,o c c u r .
Interestingly, the immediate corticosterone precursor,
deoxycorticosterone, produced from progesterone by
21-hydroxylase, was shown to have a low glucocorticoid
effect [44,45]. In the present study, steroidogenic activity
experiments showed deoxycorticosterone production by
fetal lungs through 21-hydroxylase activity, as also
reported in [46]. In addition, based on the reported affi-
nity of deoxycorticosterone for the mineralocorticoid
receptor [47] and on the very low aldosterone synthase
mRNA level in fetal lungs ([22] and data not shown),
one would suggest that this steroid could have also
mineralocorticoid effects in the lung.
Incubation of GD 17.5 lung explants in the presence
of ACTH led to a non-significant 1.5-fold increase in
Cyp21a1 expression, and the stimulatory effect of CRH
on Cyp21a1 did not involve an increase in Pomc mRNA
expression. Therefore, if CRH acted through ACTH, it
would rather be at another regulatory level, such as pro-
hormone processing or hormone release. A similar slight
but not statistically significant effect of ACTH was
observed on the capability of thymic epithelial cells to
stimulate a glucocorticoid-regulated reporter system
[21]. Further studies are needed to clarify whether a
local HPA axis-like regulatory pathway is functional in
the fetal lung as it is the case in the adult skin, where
glucocorticoid production has been shown to be regu-
lated by a local cascade of CRH and ACTH production
and signaling [19].
In epithelial- and mesenchymal-enriched primary cell
cultures, Crh, Crhr1,a n dCrhr2b were not or barely
detected whereas Cyp11b1 and Cyp21a1 were detected
at relatively high levels. A different situation was
observed in total lungs for these five genes. Such notice-
able differences in expression levels between primary
cell cultures and total lungs were not observed for the
other studied genes. These discrepancies should not
arise from cell enrichment but rather from dysregulation
of regulatory pathways that are active in the whole tis-
sue because: Crh expression was undetectable in both
epithelial-enriched and mesenchymal-enriched cell cul-
tures but was clearly detected in vivo by in situ hybridi-
zation in cell types that are represented in cell cultures,
and; mRNA levels of Cyp11b1 were elevated in both
epithelial-enriched and mesenchymal-enriched cell cul-
tures in contrast to whole lungs where only barely
detectable levels were detected. Accordingly, cell-cell
communication between mesenchymal and epithelial
cells was reported in the developing lung [48], and may
be involved in the in vivo regulation of the above-men-
tioned genes. Results from our co-culture experiments
suggest that such a potential regulation is not explained
alone by secreted factors from epithelial and mesenchy-
mal cells. A similar situation was also observed in the
lung where glucocorticoids had differential effects on
the expression of Nr3c1 in fetal lung primary cell cul-
tures compared to whole fetal lung tissues in the rat [49].
Our data suggest paracrine and/or autocrine regula-
tion and action of CRH and POMC-related peptide(s) in
the developing lung. However, an effect of circulating
ligands on specific CRH and ACTH receptors expressed
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Page 11 of 14in the lung is not excluded. Noteworthily, changes in
expression sites of the studied receptors also suggest dif-
ferent functions according to the developmental status
of the tissue.
Crh mRNA was detected at higher levels in fetal lung
samples than in control tissues, including the adult lung,
which is consistent with a specific role for CRH in lung
development (Figure 1). Accordingly, detection of Crh
mRNA by in situ hybridization was reported on GD
12.5 in the mouse lung around branching bronchioles
with an increase until GD 15.5, followed by a constant
expression level until GD 17.5, while no signal was
detected on GD 18.5 and postnatal day 1 [11]. However,
t h ec h a n g ei nCrh expression sites that we present here
was not reported in that study. Interestingly, in a pre-
vious microarray analysis in mouse fetal lungs, Crh
expression was significantly higher in lungs from males
exposed to the anti-androgen flutamide compared to
control males (~50% increase, p < 0.05), suggesting an
inhibitory effect of endogenous androgens on Crh
expression [27]. We observed by QPCR that Crh mRNA
levels tended to increase between GD 15.5 and 17.5,
while levels of Crhbp tended to decrease. This is sugges-
tive of an increased CRH bioactivity considering the
inhibitory action of CRHBP on CRH signaling [33].
Crhbp was the only gene showing a significant sex dif-
ference in expression in the present study. Interestingly,
a sex dimorphism in Crhbp expression was reported in
the mouse pituitary gland [50]. Crhr1 mRNA was
detected at very low levels in fetal lungs. However, the
fact that its expression is limited to a low proportion of
cells may explain the low mRNA levels measured from
total lung extracts. Similarly to our Crhr1 expression
data, an important interindividual variability in CRHR1
mRNA levels was observed in developing fetal baboon
lungs, with detection in about 30% of samples on GD
125 (term ~180 days) [14].
Interestingly, Crhr1 and Pomc mRNAs are co-localized
on GD 15.5 and 16.5 in cells surrounding the proximal
epithelium. In contrast, this staining pattern was not
observed on GD 17.5. These results suggest that CRHR1
signaling could lead to ACTH production in a develop-
mental time-specific manner. However, the question
whether MC2R ligand is produced in the lung or is
imported from the circulation still remains. The detec-
tion of immunoreactive ACTH in cells adjacent to those
expressing Pomc mRNA (GD 15.5-16.5) and in Pomc
mRNA-positive cells (GD 17.5) suggests a paracrine/
autocrine action of ACTH. Gene expression of several
prohormone convertases [51], namely FURIN, endopro-
tease PACE4, proprotein convertase subtilisin/kexin
(PCSK) type 5, and PCSK7 were detected in the devel-
oping mouse lung at GD 17.0 and 18.0 by DNA micro-
arrays [27]. Pc1/3, which encodes the prohormone
convertase 1/3 that is associated to ACTH production
in the pituitary, was not detected in this gene profiling
experiment. However, FURIN and PACE4 have been
shown to yield ACTH from POMC [52].
This report shows a transition in expression sites
between GD 15.5 and 17.5 for all the studied genes (Fig-
ures 2 and 3). These developmental time-specific
expression profiles are partly supported by QPCR data
obtained from mesenchymal- and epithelial-enriched
primary cell cultures (Figure 4). On GD 17.5, expression
of every gene was mainly localized in the distal epithe-
lium. This pattern of expression is interesting in the
context of lung maturation since the surge of surfactant
production occurs on GD 17 in some epithelial cells of
this epithelium. Thus, a role for CRH/ACTH in matura-
tion and/or development of the distal epithelium is
envisaged.
Conclusions
Temporal and spatial expression patterns of HPA axis-
related genes in fetal lungs during late gestation suggest
local roles for CRH and POMC/ACTH in lung develop-
ment. Our data are likely to lead to valuable insights in
relation to lung diseases originating from lung
immaturity.
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